Literature DB >> 1458452

Abnormalities of chromosome 22 in meningiomas and confirmation of the origin of a dicentric 22 by in situ hybridization.

V Tonk1, P Osella, A Delasmorenas, H E Wyandt, A Milunsky.   

Abstract

We report three cases of meningioma. Case 1 had a dicentric chromosome number 22 resulting in partial monosomy for a portion of the q-arm, i.e., 46,XX,idic(22)(pter-->q11.2::q11.2-->pter) and 46,XX,psu dic(22)(pter-->q11.2::q11.2-->pter), which was the sole clonal abnormality. The origin of the dicentric chromosome from 22 was confirmed by in situ hybridization studies, using biotin-labeled alpha centromeric DNA probes for the acrocentric chromosomes. Case 2 had two distinct clonal abnormalities: deletion of 22q and monosomy of 22. Case 3 also had a deleted 22q.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458452     DOI: 10.1016/0165-4608(92)90325-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.

Authors:  E Schröck; G Thiel; T Lozanova; S du Manoir; M C Meffert; A Jauch; M R Speicher; P Nürnberg; S Vogel; W Jänisch
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

2.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

3.  Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity.

Authors:  Jean Bouquet De Jolinière; Jean Marc Bernard Ayoubi; Luca Gianaroli; Jean Bernard Dubuisson; Jean Gogusev; Anis Feki
Journal:  Front Surg       Date:  2014-05-27

4.  Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Authors:  S Hemmer; V M Wasenius; S Knuutila; H Joensuu; K Franssila
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.